Shimamoto Akiko, Rappeneau Virginie
Department of Neuroscience and Pharmacology, School of Medicine, Meharry Medical College, 1005 Dr. D.B. Todd Jr. Blvd., Nashville, TN 37028-3599, United States.
Department of Neuroscience and Pharmacology, School of Medicine, Meharry Medical College, 1005 Dr. D.B. Todd Jr. Blvd., Nashville, TN 37028-3599, United States.
Schizophr Res. 2017 Sep;187:38-46. doi: 10.1016/j.schres.2017.02.025. Epub 2017 Mar 6.
The prevalence of some mental illnesses, including major depression, anxiety-, trauma-, and stress-related disorders, some substance use disorders, and later onset of schizophrenia, is higher in women than men. While the higher prevalence in women could simply be explained by socioeconomic determinants, such as income, social status, or cultural background, extensive studies show sex differences in biological, pharmacokinetic, and pharmacological factors contribute to females' vulnerability to these mental illnesses. In this review, we focus on estrogens, chronic stress, and neurotoxicity from behavioral, pharmacological, biological, and molecular perspectives to delineate the sex differences in these mental illnesses. Particularly, we investigate a possible role of mitochondrial function, including biosynthesis, bioenergetics, and signaling, on mediating the sex differences in psychiatric disorders.
包括重度抑郁症、焦虑症、创伤及应激相关障碍、某些物质使用障碍以及精神分裂症晚发型在内的一些精神疾病,在女性中的患病率高于男性。虽然女性患病率较高可能仅仅由社会经济决定因素来解释,比如收入、社会地位或文化背景,但广泛的研究表明,生物、药代动力学和药理学因素方面的性别差异导致女性更容易患这些精神疾病。在本综述中,我们从行为、药理学、生物学和分子角度重点关注雌激素、慢性应激和神经毒性,以阐明这些精神疾病中的性别差异。特别是,我们研究线粒体功能(包括生物合成、生物能量学和信号传导)在介导精神疾病性别差异方面可能发挥的作用。